This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Safety and Tolerability of Intravenous LFG316 in W...
Clinical trial

Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).

Read time: 1 mins
Last updated:3rd May 2012
This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of successive intravenous (IV) doses of LFG316 in eligible patients with neovascular age-related macular degeneration (AMD)
Category Value
Study start date 2012-05-03

View full details